Aptahem AB (publ) APTA.ST
APTA.ST
Aptahem AB (publ) FLUI.ST
Fluicell AB (publ) SPERM.ST
Spermosens AB STABL.ST
Stayble Therapeutics AB (publ) ODI.ST
ODI Pharma AB PROGEN.ST
Prostatype Genomics AB (publ) LIDDS.ST
LIDDS AB (publ) QUIA.ST
Quia Pharma AB (publ) CMH.ST
Chordate Medical Holding AB (publ) 2CUREX.ST
2cureX AB (publ)
Aptahem AB (publ) FLUI.ST
Fluicell AB (publ) SPERM.ST
Spermosens AB STABL.ST
Stayble Therapeutics AB (publ) ODI.ST
ODI Pharma AB PROGEN.ST
Prostatype Genomics AB (publ) LIDDS.ST
LIDDS AB (publ) QUIA.ST
Quia Pharma AB (publ) CMH.ST
Chordate Medical Holding AB (publ) 2CUREX.ST
2cureX AB (publ)
Performance
| Periode | APTA.ST | FLUI.ST | SPERM.ST | STABL.ST | ODI.ST | PROGEN.ST | LIDDS.ST | QUIA.ST | CMH.ST | 2CUREX.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -24.38 % | 9.24 % | -20.00 % | -54.71 % | -40.19 % | -66.67 % | 21.22 % | -76.98 % | -9.11 % | 152.53 % |
| YTD | -14.93 % | -40.86 % | -45.45 % | -61.90 % | -48.80 % | -93.55 % | -40.60 % | -75.63 % | -45.06 % | 273.75 % |
| 1Y | -18.87 % | -46.63 % | -66.97 % | -65.20 % | -59.75 % | -94.89 % | -50.50 % | -84.32 % | -87.43 % | 169.37 % |
| 3Y | -97.55 % | -98.65 % | -99.81 % | -94.39 % | -74.50 % | -99.90 % | -98.67 % | -99.96 % | -98.84 % | -82.97 % |
| 5Y | -99.30 % | -99.54 % | -99.91 % | -97.43 % | -73.44 % | -99.97 % | -99.57 % | -100.00 % | -98.86 % | -90.32 % |
| 10Y | -99.84 % | -99.76 % | -99.91 % | -97.13 % | -86.89 % | -99.97 % | -99.32 % | -100.00 % | -98.86 % | -80.35 % |
| Depuis le début | -99.85 % | -99.76 % | -99.91 % | -97.13 % | -86.89 % | -99.97 % | -99.43 % | -100.00 % | -98.86 % | -80.35 % |